Rod Amir Rahimi, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocyte Subsets | 2 | 2020 | 1914 | 0.830 |
Why?
|
Immunologic Memory | 3 | 2020 | 1403 | 0.720 |
Why?
|
Transforming Growth Factor beta | 5 | 2019 | 1977 | 0.640 |
Why?
|
Chemokines | 1 | 2018 | 958 | 0.510 |
Why?
|
Muscle Weakness | 1 | 2012 | 414 | 0.390 |
Why?
|
Lampreys | 1 | 2008 | 32 | 0.380 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 504 | 0.370 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 451 | 0.310 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 1100 | 0.280 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2012 | 1139 | 0.250 |
Why?
|
Intensive Care Units | 1 | 2012 | 3263 | 0.190 |
Why?
|
Transcription Factors | 2 | 2009 | 11910 | 0.180 |
Why?
|
Myofibroblasts | 2 | 2017 | 217 | 0.180 |
Why?
|
Arteritis | 1 | 2019 | 128 | 0.170 |
Why?
|
Trans-Activators | 1 | 2009 | 3150 | 0.170 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 110 | 0.170 |
Why?
|
Receptors, Cytokine | 1 | 2018 | 264 | 0.170 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 671 | 0.160 |
Why?
|
Lymphoid Tissue | 1 | 2018 | 502 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3964 | 0.150 |
Why?
|
Lectins, C-Type | 1 | 2019 | 617 | 0.150 |
Why?
|
Receptors, Chemokine | 1 | 2018 | 675 | 0.140 |
Why?
|
Carrier Proteins | 1 | 2009 | 5257 | 0.140 |
Why?
|
Fibroblasts | 3 | 2010 | 4345 | 0.130 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2013 | 172 | 0.130 |
Why?
|
Aniline Compounds | 1 | 2017 | 943 | 0.120 |
Why?
|
Terminology as Topic | 1 | 2020 | 1652 | 0.120 |
Why?
|
Oncogene Proteins v-erbB | 1 | 2010 | 20 | 0.110 |
Why?
|
Smad Proteins | 2 | 2010 | 185 | 0.110 |
Why?
|
Dendritic Cells | 2 | 2019 | 2779 | 0.110 |
Why?
|
Signal Transduction | 5 | 2019 | 24351 | 0.100 |
Why?
|
Apoptosis | 3 | 2017 | 10261 | 0.100 |
Why?
|
Pulmonary Fibrosis | 1 | 2013 | 488 | 0.100 |
Why?
|
Oncogene Protein v-akt | 1 | 2009 | 143 | 0.090 |
Why?
|
Animals | 11 | 2020 | 170849 | 0.090 |
Why?
|
Cell Movement | 2 | 2019 | 5671 | 0.090 |
Why?
|
Sulfonamides | 1 | 2017 | 1961 | 0.090 |
Why?
|
Gene Duplication | 1 | 2008 | 341 | 0.080 |
Why?
|
Dogs | 2 | 2010 | 4269 | 0.080 |
Why?
|
Biochemistry | 1 | 2007 | 123 | 0.080 |
Why?
|
Neural Crest | 1 | 2008 | 287 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4115 | 0.080 |
Why?
|
HeLa Cells | 2 | 2010 | 3395 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2012 | 1131 | 0.070 |
Why?
|
Mesoderm | 1 | 2007 | 749 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2012 | 1105 | 0.070 |
Why?
|
Body Patterning | 1 | 2008 | 652 | 0.070 |
Why?
|
Macrophages | 1 | 2019 | 5748 | 0.070 |
Why?
|
Lymphoma | 1 | 2012 | 1863 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2013 | 2212 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2253 | 0.060 |
Why?
|
Epithelium | 1 | 2007 | 1774 | 0.060 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1178 | 0.060 |
Why?
|
Pneumonia | 1 | 2012 | 1942 | 0.060 |
Why?
|
Methylmercury Compounds | 1 | 2003 | 162 | 0.060 |
Why?
|
Oncogenes | 1 | 2007 | 1212 | 0.060 |
Why?
|
Sirolimus | 1 | 2009 | 1605 | 0.050 |
Why?
|
Phylogeny | 1 | 2008 | 2863 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2007 | 3969 | 0.050 |
Why?
|
Ganglia, Spinal | 1 | 2003 | 528 | 0.050 |
Why?
|
Integrin alphaV | 1 | 2019 | 55 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10329 | 0.050 |
Why?
|
Evolution, Molecular | 1 | 2008 | 2032 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2833 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2103 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 2842 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2902 | 0.040 |
Why?
|
Mitochondrial Membranes | 1 | 2017 | 167 | 0.040 |
Why?
|
Phosphorylation | 1 | 2009 | 8896 | 0.040 |
Why?
|
bcl-X Protein | 1 | 2017 | 413 | 0.040 |
Why?
|
Epidermis | 1 | 2019 | 557 | 0.040 |
Why?
|
Dermis | 1 | 2017 | 214 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2009 | 3715 | 0.040 |
Why?
|
Candida albicans | 1 | 2019 | 370 | 0.040 |
Why?
|
Mice | 5 | 2019 | 80803 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 23439 | 0.040 |
Why?
|
Vasculitis | 1 | 2019 | 526 | 0.040 |
Why?
|
Humans | 7 | 2020 | 686663 | 0.040 |
Why?
|
Inflammasomes | 1 | 2019 | 384 | 0.040 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 279 | 0.040 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 537 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2019 | 944 | 0.030 |
Why?
|
Proteins | 1 | 2009 | 6264 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2019 | 2238 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2017 | 494 | 0.030 |
Why?
|
Bleomycin | 1 | 2013 | 486 | 0.030 |
Why?
|
Pulmonary Gas Exchange | 1 | 2013 | 388 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2013 | 298 | 0.030 |
Why?
|
Swiss 3T3 Cells | 1 | 2010 | 5 | 0.030 |
Why?
|
Fibrosis | 1 | 2017 | 1798 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2013 | 641 | 0.030 |
Why?
|
Aorta | 1 | 2019 | 2133 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2013 | 488 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2013 | 749 | 0.030 |
Why?
|
Models, Biological | 1 | 2007 | 10102 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2010 | 427 | 0.020 |
Why?
|
Phenotype | 1 | 2007 | 16091 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2643 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1814 | 0.020 |
Why?
|
Drug Interactions | 1 | 2013 | 1465 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3425 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1420 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 807 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 2892 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2019 | 3101 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 6288 | 0.020 |
Why?
|
Cell Line | 2 | 2013 | 17137 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3196 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 10094 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1418 | 0.020 |
Why?
|
Neutrophils | 1 | 2019 | 3876 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4456 | 0.020 |
Why?
|
Mitochondria | 1 | 2017 | 3602 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4441 | 0.020 |
Why?
|
Neurons | 1 | 2003 | 9331 | 0.020 |
Why?
|
PC12 Cells | 1 | 2003 | 352 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2010 | 3385 | 0.020 |
Why?
|
Piperazines | 1 | 2013 | 2576 | 0.010 |
Why?
|
Neurites | 1 | 2003 | 386 | 0.010 |
Why?
|
Pyrimidines | 1 | 2013 | 2909 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 3053 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 9617 | 0.010 |
Why?
|
Male | 2 | 2017 | 352465 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18495 | 0.010 |
Why?
|
Adult | 1 | 2012 | 211400 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5252 | 0.010 |
Why?
|
Female | 2 | 2012 | 375459 | 0.010 |
Why?
|
Lung | 1 | 2013 | 9182 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8707 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 11616 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 8130 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2003 | 20620 | 0.000 |
Why?
|
Rats | 1 | 2003 | 25307 | 0.000 |
Why?
|
Pregnancy | 1 | 2003 | 25703 | 0.000 |
Why?
|